Literature DB >> 18329789

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.

Jörg Ellinger1, Patrick J Bastian, Nadja Ellinger, Philip Kahl, Frank G Perabo, Reinhard Büttner, Stefan C Müller, Alexander von Ruecker.   

Abstract

Patients with malignancies often possess increased concentrations of cell-free serum DNA. In this study, we investigated serum DNA levels in each 45 patients with bladder cancer (BCA) undergoing radical cystectomy and with benign prostate hyperplasia. A quantitative real-time PCR was used to amplify a 124 bp (PTGS2; mostly apoptotic origin) and a 271 bp (Reprimo; mostly necrotic origin) DNA fragment. Changes in the origin of DNA fragments were specified as the Apoptosis Index (AI, ratio of 124 bp/271 bp fragments). Small and large fragments were increased (p<0.001 and p=0.041) in BCA patients. The AI increase suggests that DNA fragmentation was mostly (p<0.001) caused by apoptosis. High levels of small DNA fragments distinguished between BCA and BPH with high sensitivity (96%) and moderate specificity (62%). DNA levels and the AI were not correlated with clinicopathological parameters. However, an increased AI was correlated with BCA-specific mortality in a multivariate analysis (p=0.011) indicating that the AI is an independent prognostic factor. Thus, cell-free DNA seems to be a useful prognostic marker in patients with BCA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329789     DOI: 10.1016/j.canlet.2008.01.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  [Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies].

Authors:  J Ellinger; A von Rücker; P J Bastian; S C Müller
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 2.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

Review 3.  Cell-free DNA in blood and urine as a diagnostic tool for bladder cancer: a meta-analysis.

Authors:  Xin-Shuai Wang; Meng-Qi Zhao; Li Zhang; De-Jiu Kong; Xue-Zhen Ding; Xiao-Chen Hu; Jun-Qiang Yang; She-Gan Gao
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

4.  Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.

Authors:  Swati Kumari; Shikha Tewari; Nuzhat Husain; Akash Agarwal; Anshuman Pandey; Ashish Singhal; Mohtashim Lohani
Journal:  Pathol Oncol Res       Date:  2016-07-30       Impact factor: 3.201

5.  Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients.

Authors:  Marcelo L Wroclawski; Ary Serpa-Neto; Fernando L A Fonseca; Oseas Castro-Neves-Neto; Alexandre S F L Pompeo; Marcos T Machado; Antonio C L Pompeo; Auro del Giglio
Journal:  Tumour Biol       Date:  2013-05-29

Review 6.  The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.

Authors:  Michael Rink; Heidi Schwarzenbach; Sabine Riethdorf; Armin Soave
Journal:  World J Urol       Date:  2018-10-26       Impact factor: 4.226

Review 7.  Stance of MRD in Non-Hodgkin's Lymphoma and its upsurge in the novel era of cell-free DNA.

Authors:  S Garg; A Kumar; R Gupta
Journal:  Clin Transl Oncol       Date:  2021-05-15       Impact factor: 3.405

8.  Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.

Authors:  Alain R Thierry; Florent Mouliere; Celine Gongora; Jeremy Ollier; Bruno Robert; Marc Ychou; Maguy Del Rio; Franck Molina
Journal:  Nucleic Acids Res       Date:  2010-05-21       Impact factor: 16.971

Review 9.  Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?

Authors:  Hunter R Underhill
Journal:  Mol Diagn Ther       Date:  2021-05-20       Impact factor: 4.074

10.  Determination of the apoptotic index in osteosarcoma tissue and its relationship with patients prognosis.

Authors:  Xing Wu; Biao Cheng; Zheng-Dong Cai; Lie-Ming Lou
Journal:  Cancer Cell Int       Date:  2013-06-04       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.